Gokulam Lifescience Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 22.50 Cr
as on 22-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.55 Cr
as on 22-12-2024
- Revenue 121.83%
(FY 2021)
- Profit 140.40%
(FY 2021)
- Ebitda 381.42%
(FY 2021)
- Net Worth 20.85%
(FY 2021)
- Total Assets 19.84%
(FY 2021)
About Gokulam Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 22.50 Cr.
The company currently has active open charges totaling ₹19.55 Cr.
The Key Managerial Personnel (KMP) at Gokulam Lifescience Private Limited India is Jayraj Baldev as COMPANY SECRETARY. Vishal Modha and Mitul Sakhiya serve as directors at the Company.
- CIN/LLPIN
U85320GJ2018PTC101169
- Company No.
101169
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gokulam Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayraj Baldev  | Company Secretary | 29-Jan-2024 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Modha | Director | 09-Mar-2018 | Current |
| Mitul Sakhiya | Director | 09-May-2023 | Current |
Financial Performance of Gokulam Lifescience.
Gokulam Lifescience Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 121.83% increase. The company also saw a substantial improvement in profitability, with a 140.4% increase in profit. The company's net worth Soared by an impressive increase of 20.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gokulam Lifescience?
In 2021, Gokulam Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Mar 2018 | ₹19.55 Cr | Open |
How Many Employees Work at Gokulam Lifescience?
Gokulam Lifescience has a workforce of 107 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gokulam Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gokulam Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
